• Explore /
  • Poster
  • / Camrelizumab combined with FOLFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma.

Camrelizumab combined with FOLFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma.

Abstract Poster

Authors

null

Ying Liu

Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China

Ying Liu , Guangsen Han , Hongle Li , Yuzhou Zhao , Jing Zhuang , Gangcheng Wang , Baodong Li , Jinbang Wang , Zhimeng Li , Qingxin Xia , Jie Ma , Chengjuan Zhang , Juan Yu , Ke Li , Shuning Xu , Lei Qiao , Gaizhen Kuang , Danyang Li

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT03939962

Citation

J Clin Oncol 38: 2020 (suppl; abstr 4536)

DOI

10.1200/JCO.2020.38.15_suppl.4536

Abstract #

4536

Poster Bd #

144

Abstract Disclosures

Similar Posters

First Author: Ying Liu

First Author: Thierry Alcindor

First Author: Hongli Li

First Author: Haiping Jiang